ZA931984B - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
ZA931984B
ZA931984B ZA931984A ZA931984A ZA931984B ZA 931984 B ZA931984 B ZA 931984B ZA 931984 A ZA931984 A ZA 931984A ZA 931984 A ZA931984 A ZA 931984A ZA 931984 B ZA931984 B ZA 931984B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
ZA931984A
Inventor
Werner Mederski
Rolf Gericke
Pierre Schelling
Norbert Beier
Klaus Otto Minck
Dieter Dorsch
Manfred Baumgarth
Rolf Bergmann
Ingeborg Lues
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA931984B publication Critical patent/ZA931984B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA931984A 1992-03-20 1993-03-19 Pharmaceutical composition ZA931984B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4209071A DE4209071A1 (en) 1992-03-20 1992-03-20 PHARMACEUTICAL PREPARATION

Publications (1)

Publication Number Publication Date
ZA931984B true ZA931984B (en) 1993-10-19

Family

ID=6454609

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931984A ZA931984B (en) 1992-03-20 1993-03-19 Pharmaceutical composition

Country Status (13)

Country Link
EP (1) EP0561357A1 (en)
JP (1) JPH0648961A (en)
KR (1) KR930019215A (en)
CN (1) CN1076357A (en)
AU (1) AU3528593A (en)
CA (1) CA2091942A1 (en)
DE (1) DE4209071A1 (en)
HU (1) HUT63764A (en)
MX (1) MX9301546A (en)
NO (1) NO931014L (en)
PL (1) PL298159A1 (en)
TW (1) TW237384B (en)
ZA (1) ZA931984B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5574049A (en) * 1994-07-22 1996-11-12 Sandoz Ltd. 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3915236A1 (en) * 1989-05-10 1990-11-15 Merck Patent Gmbh PHARMACEUTICAL PREPARATION
DE4004268A1 (en) * 1990-02-13 1991-08-14 Merck Patent Gmbh PHARMACEUTICAL PREPARATION

Also Published As

Publication number Publication date
PL298159A1 (en) 1993-10-18
KR930019215A (en) 1993-10-18
DE4209071A1 (en) 1993-09-23
NO931014D0 (en) 1993-03-19
HUT63764A (en) 1993-10-28
AU3528593A (en) 1993-09-23
EP0561357A1 (en) 1993-09-22
CA2091942A1 (en) 1993-09-21
MX9301546A (en) 1993-09-01
JPH0648961A (en) 1994-02-22
TW237384B (en) 1995-01-01
CN1076357A (en) 1993-09-22
NO931014L (en) 1993-09-21
HU9300796D0 (en) 1993-06-28

Similar Documents

Publication Publication Date Title
GB9224855D0 (en) Pharmaceutical compositions
GB9209078D0 (en) Pharmaceutical compositions
GB9319500D0 (en) Pharmaceutical composition
HUT66864A (en) Pharmaceutical compositions
GB2272375B (en) Pharmaceutical composition
EP0587047A3 (en) Gestagenes containing pharmaceutical composition
GB9209874D0 (en) Pharmaceutical compositions
CA2100836A1 (en) Pharmaceutical Composition
GB9221707D0 (en) Pharmaceutical composition
ZA94155B (en) Pharmaceutical composition
ZA935078B (en) Pharmaceutical composition
GB9226377D0 (en) Pharmaceutical compositions
ZA935931B (en) Pharmaceutical composition
ZA924061B (en) Pharmaceutical composition
GB9211276D0 (en) Pharmaceutical compositions
ZA931984B (en) Pharmaceutical composition
GB9225159D0 (en) Pharmaceutical composition
GB9221003D0 (en) Pharmaceutical composition
GB9225170D0 (en) Pharmaceutical composition
GB9206046D0 (en) Pharmaceutical composition
GB9209520D0 (en) Pharmaceutical composition
GB9203897D0 (en) Pharmaceutical composition
GB9215976D0 (en) Pharmaceutical composition
GB9204472D0 (en) Pharmaceutical composition
GB9216600D0 (en) Pharmaceutical composition